Clinical trial
The Effect of Sitaxsentan Once Daily Dosing on Proteinuria, 24-hour Systemic Blood Pressure, and Arterial Stiffness in Subjects With Chronic Kidney Disease
NCT00817037 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Sitaxsentan Once Daily Dosing on Proteinuria, 24-hour Systemic Blood Pressure, and Arterial Stiffness in Subjects With Chronic Kidney Disease
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 14, 2007
- Completion date
- July 7, 2009
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, chronic kidney disease, proteinuria